297 related articles for article (PubMed ID: 23600966)
1. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
[TBL] [Abstract][Full Text] [Related]
2. The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.
Neocleous V; Fanis P; Toumba M; Stylianou C; Picolos M; Andreou E; Kyriakou A; Iasonides M; Nicolaou S; Kyriakides TC; Tanteles GA; Skordis N; Phylactou LA
Horm Metab Res; 2019 Sep; 51(9):586-594. PubMed ID: 31505704
[TBL] [Abstract][Full Text] [Related]
3. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
[TBL] [Abstract][Full Text] [Related]
5. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population.
Baumgartner-Parzer SM; Nowotny P; Heinze G; Waldhäusl W; Vierhapper H
J Clin Endocrinol Metab; 2005 Feb; 90(2):775-8. PubMed ID: 15572419
[TBL] [Abstract][Full Text] [Related]
6. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia.
Skordis N; Kyriakou A; Tardy V; Ioannou YS; Varvaresou A; Dracopoulou-Vabouli M; Patsalis PC; Shammas C; Neocleous V; Phylactou LA
Horm Res Paediatr; 2011; 75(3):180-6. PubMed ID: 20838032
[TBL] [Abstract][Full Text] [Related]
7. Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia.
Marques CJ; Pignatelli D; Carvalho B; Barceló J; Almeida AC; Fernandes S; Witchel SF; Sousa M; Oliveira MJ; Freitas P; Fontoura M; Carvalho D; Barros A; Carvalho F
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):505-12. PubMed ID: 19856253
[TBL] [Abstract][Full Text] [Related]
8. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
[TBL] [Abstract][Full Text] [Related]
10. Genetic defects of the CYP21A2 gene in girls with premature adrenarche.
Skordis N; Shammas C; Phedonos AA; Kyriakou A; Toumba M; Neocleous V; Phylactou LA
J Endocrinol Invest; 2015 May; 38(5):535-9. PubMed ID: 25481255
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
12. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.
Grigorescu Sido A; Weber MM; Grigorescu Sido P; Clausmeyer S; Heinrich U; Schulze E
J Clin Endocrinol Metab; 2005 Oct; 90(10):5769-73. PubMed ID: 16046588
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the CYP21A2 gene in congenital adrenal hyperplasia.
Forouzanfar K; Seifi M; Hashemi-Gorji F; Karimi N; Estiar MA; Karimoei M; Sakhinia E; Karimipour M; Ghergherehchi R
Cell Mol Biol (Noisy-le-grand); 2015 Aug; 61(4):51-5. PubMed ID: 26278268
[TBL] [Abstract][Full Text] [Related]
14. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
[TBL] [Abstract][Full Text] [Related]
15. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
16. [Detection of CYP21A2 gene mutations and the differences in the levels of hormones in patients with 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):586-592. PubMed ID: 32164112
[No Abstract] [Full Text] [Related]
17. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
18. Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes.
Koppens PF; Hoogenboezem T; Degenhart HJ
Hum Genet; 2002 Oct; 111(4-5):405-10. PubMed ID: 12384784
[TBL] [Abstract][Full Text] [Related]
19. In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia.
Barbaro M; Soardi FC; Östberg LJ; Persson B; de Mello MP; Wedell A; Lajic S
Clin Endocrinol (Oxf); 2015 Jan; 82(1):37-44. PubMed ID: 24953648
[TBL] [Abstract][Full Text] [Related]
20. Carrier detection and prenatal diagnosis of congenital adrenal hyperplasia must identify 'apparently mild' CYP21A2 alleles which associate neonatal salt-wasting disease.
Ezquieta B; Santomé L; Barrio R; Barrionuevo JL; López-Siguero JP; Oliver A; Ramírez J; Rodríguez I; Muñoz-Pacheco R
Prenat Diagn; 2010 Aug; 30(8):758-63. PubMed ID: 20661889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
